跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OMVOH - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OMVOH
Authorized
STANDARD
OMVOH
eli lilly canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
13491c2afd92ec3f
Company
eli lilly canada inc
Type
Standard
Approval Details
Approval Id
13491c2afd92ec3f
Drug Approval Canada Name
OMVOH
Product Name
OMVOH
Status
Marketed
Status Date
2023-12-05
Original Market Date
2023-12-05
Din
02539845
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
56:44.00
Atc Original
L04AC24 MIRIKIZUMAB
Atc Name
l 04 ac 24
Aig Number
0164841001
Company Name
eli lilly canada inc
Company Address
SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1
Active Ingredients
MIRIKIZUMAB
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
13491c2afd92ec3f
Type
Standard
Back to Health Canada Approvals